Literature DB >> 25674345

Transcranial direct middle meningeal artery puncture for the onyx embolization of dural arteriovenous fistula involving the superior sagittal sinus.

Jae-Sang Oh1, Seok-Mann Yoon1, Jai-Joon Shim1, Hack-Gun Bae1.   

Abstract

A 66-year-old woman presented with intermittent paraparesis and generalized tonic-clonic seizure. Cerebral angiography demonstrated dural arteriovenous fistula (AVF) involving superior sagittal sinus (SSS), which was associated with SSS occlusion on the posterior one third. The dural AVF was fed by bilateral middle meningeal arteries (MMAs), superficial temporal arteries (STAs) and occipital arteries with marked retrograde cortical venous reflux. Transfemoral arterial Onyx embolization was performed through right MMA and STA, but it was not successful, which resulted in partial obliteration of dural AVF because of tortuous MMA preventing the microcatheter from reaching the fistula closely enough. Second procedure was performed through left MMA accessed by direct MMA puncture following small decortications of cranium overlying the MMA using diamond drill one week later. Microcatheter could be located far distally to the fistula through 5 F sheath placed into the MMA and complete obliteration of dural AVF was achieved using 3.9 cc of Onyx.

Entities:  

Keywords:  Dural arteriovenous fistula; Middle meningeal artery; Onyx embolization; Superior sagittal sinus; Transcranial

Year:  2015        PMID: 25674345      PMCID: PMC4323506          DOI: 10.3340/jkns.2015.57.1.54

Source DB:  PubMed          Journal:  J Korean Neurosurg Soc        ISSN: 1225-8245


INTRODUCTION

Dural arteriovenous fistulas (dAVFs) of the superior sagittal sinus (SSS) account for 8-11% of intracranial dural fistulas1,4). Treatment is often challenging because of multiple and bilateral arterial feeders, most commonly the middle meningeal arteries (MMAs). Transarterial embolization and surgical coagulation of draining vein are preferred treatment options for SSS fistulas, especially in the anterior third of SSS. However, due to the penetration capability of Onyx, transarterial Onyx embolization can result in complete obliteration of dAVF in post-Onyx era. It is important to locate the tip of microcatheter near the fistula as close as possible to obliterate fistula successfully with Onyx. However, superselection of MMA feeders is not always possible when proximal part of MMA is tortuous. Recently, a combination of surgical and endovascular techniques, including direct-puncture transvenous embolization during surgery or transvenous embolization alone, has been described. And we introduced a case of DAVF within the wall of SSS associated with cortical venous reflux, which was embolized with direct puncture technique after failed initial conventional transarterial endovascular therapy.

CASE REPORT

Case presentation

A-66-year-old woman was transferred to our hospital for the evaluation of intermittent paraparesis. She had a history of head injury, which was acute subdural hematoma managed conservatively 3 years ago in our hospital. She has been doing well without sequale even though she complained of intermittent headache for 2 years. On admission, she complained of gait ataxia because of intermittent paraparesis, which was more severe in the left lower extremity, and left hand tremor for 2 weeks. However, her weakness was not definite on neurologic examination. Whole spine magnetic resonance image (MRI) demonstrated no abnormal findings, but brain MRI revealed multiple signal void lesions on both fronto-parietal convexity suggesting vascular lesion (Fig. 1), which was not visible on previous MRI performed 3 years ago. Before the planned cerebral angiography was done, sudden generalized tonic-clonic seizure was developed.
Fig. 1

Brain magnetic resonance image showing multiple microbleeding (arrowheads) along the sulci of cerebral convexities on gradient echo image (A) and multiple vascular signals (arrows) on both centrum semiovale on gadolinium enhanced T1-weighted image (B).

Angiography depicted a dAVFs on the SSS fed by both MMAs, superficial temporal arteries (STAs) and occipital arteries (OAs) and drained into the occluded SSS retrograde fashion, then mark-ed reflux to bilateral superficial cortical veins. There was no feeder from both internal carotid arteries. Because the SSS was occluded at the posterior one third, most cerebral venous outflow was drained into deep venous system through internal cerebral vein and straight sinus to transverse sigmoid sinus (Fig. 2). These dAVFs were classified as type IIa+IIb according to Cognard et al.1).
Fig. 2

Angiography depicting dural arteriovenous fistulas on superior saggittal sinus (SSS) fed by both middle meningeal arteries (arrowheads), superficial temporal arteries (arrows) and occipital arteries (A) and draining into the occluded SSS retrograde fashion, then marked reflux to bilateral superficial cortical veins (B). There was no feeder from both internal carotid arteries and most cerebral venous outflow was drained into deep venous system through internal cerebral vein and straight sinus to transverse sigmoid sinus (C).

Endovascular embolization

1st embolization

Under the general anesthesia, bilateral femoral arterial punctures were done. Through right femoral artery, a 6 F Envoy (Cordis, Miami, FL, USA) guiding catheter was advanced to the right external carotid artery (ECA). And a 5 F diagnostic catheter was placed to the left common carotid artery to evaluate the degree of dAVFs obliteration during the procedures. Initially, Echelon-10 (ev3 Neurovascular, Irvine, CA, USA) microcatheter was navigated through the 6 F guiding catheter, but it was very difficult to navigate the tortuous turning point beyond the foramen spinosum level (Fig. 3A). Thus, the microcatheter was changed to Marathon (ev3 Neurovascular, Irvine, CA, USA) catheter, however, it was impossible to get access the fistula portion. Thus Onyx injection was done from the proximal frontal branch of MMA, but resulted in the incomplete obliteration.
Fig. 3

Radiologic images obtained during first embolization session. Lateral view of roadmap image showing the tortuous turning point (arrow) beyond the foramen spinosum level (A). Postoperative skull radiographs showing the Onyx cast after incomplete embolization (B). Postoperative angiogram showing the incomplete obliteration of dAVFs (C). dAVFs : dural arteriovenous fistulas.

So, we performed Onyx embolization from the petrosal branch of MMA and the parietal branch of STA. Total of 4 cc Onyx was injected during the first session through right ECA branches. However, the infiltration of Onyx into the fistula was not successful from these vessels (Fig. 3B, C).

2nd embolization

Even though her paraparesis was improved a lot after the first incomplete embolization of dural AVF, 2nd procedure was inevitable to prevent fatal hemorrhage, or seizure. 2nd embolization was composed of direct MMA puncture through the small decortication on the left frontal bone overlying the MMA beyond the turning point. After one week, left transcranial arterial embolization was performed under the general anesthesia in the angiosuite. She was placed on supine position and the head was rotated 60 degree to the opposite side. A 5 F diagnostic catheter was placed to left ECA with continuous heparinized saline irrigation. Under the roadmap guidance, exact location of MMA to be punctured was marked with drill tip (Fig. 4A). After a small semilunar shaped scalp incision was made, decortication of temporal bone using diamond drill was performed on the distal part of turning point of MMA (Fig. 4B). A 10 mg of verapamil was infused through the catheter to dilate the MMA because it was not large enough to puncture successfully.
Fig. 4

Roadmap image showing the dilling point of MMA (A). Intraoperative photograph demonstrating decortication of temporal bone using diamond drill and dilated MMA after verapamil injection (B). MMA : middle meningeal artery.

Direct puncture of MMA using 20 G angioneedle was done without difficulty. Hairwire was inserted into the MMA and 5 F micropuncture sheath was placed over the wire. This sheath was fixed with black silk tie to prevent accidental removal during the procedures (Fig. 5). Through the sheath Echelon-10 (ev3 Neurovascular, Irvine, CA, USA) microcatheter was introduced and advanced to the fistula portion near the SSS. Microangiogram demonstrated dAVF clearly. Onyx injection (total 3.9 cc) from this single artery resulted in complete obliteration of AVF without remnant (Fig. 6). And on post operative angiogram, AVF from both STAs and OAs was also completely obliteration.
Fig. 5

Photograph showing the placement of 5 F micropuncture sheath in the MMA and fixation with black silk tie to prevent accidental removal during the procedures (A). Microcatheter angiogram showing the dAVFs clearly (B). MMA : middle meningeal artery, dAVFs : dural arteriovenous fistulas.

Fig. 6

Postoperative angiograms showing the completer obliteration of dAVFs without cortical venous reflux (A and B). Postoperative skull radiographs showing the Onyx cast after complete obliteration of dAVFs (C and D). dAVFs : dural arteriovenous fistulas.

Postoperatively, she recovered well and her paraparesis was improved to normal. Diffusion weighted image showed no abnormal high signal lesion on brain parenchyma. Computerized tomography (CT) scan showed Onyx cast within the fistula and arterialized cortical veins.

DISCUSSION

DAVFs involving the SSS are rare but have aggressive clinical symptom and intracranial hemorrhage due to the venous hypertension. The resultant encephalopathy can be clinically demonstrated on dementia, gait ataxia, seizure, myelopathy, cerebral edema, ischemia, subarachnoid hemorrhage, or any combined of several these signs and symptom12). If the cortical venous reflux persists, annual risk of hemorrhage or non hemorrhagic neurological deficits is known to be 15% along with an annual mortality rate of 10.4%. Cognard et al.1) noted intracranial hemorrhage in 10% of patients with type II, 40% with type III and 65% with type IV DAVFs. Recently, there are many multimodality treatment modalities including compression, transvenous, transarterial embolization, surgery, and radiosurgery3,6). In addition, especially on DAVFs involving the SSS, a combination of surgical and endovascular techniques, including direct-puncture transvenous embolization during surgery or transvenous alone has been described4,8,10). And, stent placement for occluded sinus is an additional treatment option for DAVFs involving the SSS13). In this case, we considered many endovascular treatment options including transvenous coil embolization, SSS stenting, and transarterial Onyx embolization5,7,15). Of these, transvenous coil embolization required surgical exposure of SSS, which had a disadvantage of excessive bleeding. Although SSS stenting could convert aggressive type to benign type, it was considered difficult because the length of occlusion was long13). Therefore, we decide to try transarterial embolization with Onyx. Onyx has an advantage of nonadhesive nature and penetration capability over n-butyl-2-cyanoacrylate. There have been many successful reports on transarterial Onyx embolization of dAVFs2,8). We tried transarterial Onyx embolization using MMA, however, it was not successful because of proximal tortuousity of MMA. If we can get access to the fistula through MMA, there is a high likelihood of complete obliteration of dAVF with Onyx. To overcome the proximal tortuosity of MMA, we performed direct MMA puncture. Transcranial combined approach using direct puncture technique is sometimes very useful when a traditional transfemoral transarterial approach was failed. Many neurosurgeons has successfully treated for dAVFs using transcranial approach for venous embolization5,11). We treated this case using transcranial approach for arterial embolization. Koh et al.9) reported transcranial transarterial approach with craniectomy for occlusion of dAVFs combined with SSS. In our case we used diamond drill to decorticate the temporal bone to prevent accidental damage to MMA5,11,14). Decortication is more beneficial in cosmetic aspect and more safe for preserving the MMA, instead of burrhole or craniectomy. Then verapamil injection through the catheter can dilate MMA and prevent the vasospasm.

CONCLUSION

Transcranial combines approach using direct puncture technique may be a alternative way to occluded DAVFs with a patent sinus, or when usual transfemoral transarterial approach have failed.
  14 in total

1.  Transarterial intravenous coil embolization of dural arteriovenous fistula involving the superior sagittal sinus.

Authors:  J Fukai; T Terada; T Kuwata; G Hyotani; M Raimura; M Nakagawa; M Yabumoto; I Kamei
Journal:  Surg Neurol       Date:  2001-06

Review 2.  Combined neurosurgical and neuroradiological treatment of a complex superior sagittal sinus dural fistula: technical note.

Authors:  L Pierot; A Visot; A Boulin; M Dupuy
Journal:  Neurosurgery       Date:  1998-01       Impact factor: 4.654

Review 3.  Treatment of intracranial dural arteriovenous fistulas: current strategies based on location and hemodynamics, and alternative techniques of transcatheter embolization.

Authors:  Hiro Kiyosue; Yuzo Hori; Mika Okahara; Shuichi Tanoue; Yoshiko Sagara; Shunro Matsumoto; Hirofumi Nagatomi; Hiromu Mori
Journal:  Radiographics       Date:  2004 Nov-Dec       Impact factor: 5.333

4.  Complete Cure of Superior Sagittal Sinus Dural Arteriovenous Fistulas by Transvenous Embolization through the Thrombosed Sinus in a Single Therapeutic Session. A Case Report.

Authors:  S Toyota; Y Fujimoto; A Wakayama; T Yoshimine
Journal:  Interv Neuroradiol       Date:  2008-10-08       Impact factor: 1.610

5.  Surgical treatment of high-risk intracranial dural arteriovenous fistulae: clinical outcomes and avoidance of complications.

Authors:  Udaya K Kakarla; Vivek R Deshmukh; Joseph M Zabramski; Felipe C Albuquerque; Cameron G McDougall; Robert F Spetzler
Journal:  Neurosurgery       Date:  2007-09       Impact factor: 4.654

6.  Transcranial approach for venous embolization of dural arteriovenous fistulas.

Authors:  Emmanuel Houdart; Jean-Pierre Saint-Maurice; René Chapot; Adam Ditchfield; Alexandre Blanquet; Guillaume Lot; Jean-Jacques Merland
Journal:  J Neurosurg       Date:  2002-08       Impact factor: 5.115

Review 7.  Dural arteriovenous fistulas of superior sagittal sinus: case report and review of literature.

Authors:  S Kurl; T Saari; R Vanninen; J Hernesniemi
Journal:  Surg Neurol       Date:  1996-03

8.  Superior sagittal sinus dural arteriovenous fistulas treated by stent placement for an occluded sinus and transarterial embolization. A case report.

Authors:  N Ohara; S Toyota; M Kobayashi; A Wakayama
Journal:  Interv Neuroradiol       Date:  2012-09-10       Impact factor: 1.610

9.  Cerebral dural arteriovenous fistulas: clinical and angiographic correlation with a revised classification of venous drainage.

Authors:  C Cognard; Y P Gobin; L Pierot; A L Bailly; E Houdart; A Casasco; J Chiras; J J Merland
Journal:  Radiology       Date:  1995-03       Impact factor: 11.105

10.  Intracranial dural arteriovenous fistulas: clinical characteristics and management based on location and hemodynamics.

Authors:  Jung Tae Oh; Seung Young Chung; Giuseppe Lanzino; Ki Seok Park; Seong Min Kim; Moon Sun Park; Han Kyu Kim
Journal:  J Cerebrovasc Endovasc Neurosurg       Date:  2012-09-28
View more
  3 in total

Review 1.  Clinical importance of the middle meningeal artery: A review of the literature.

Authors:  Jinlu Yu; Yunbao Guo; Baofeng Xu; Kan Xu
Journal:  Int J Med Sci       Date:  2016-10-17       Impact factor: 3.738

2.  Onyx removal after embolization of a superior sagittal sinus dural arteriovenous fistula involving scalp artery.

Authors:  Jun Watanabe; Jun Maruya; Keiichi Nishimaki; Yasushi Ito
Journal:  Surg Neurol Int       Date:  2016-06-03

3.  Trans-Cranial Embolisation of a Complex Transverse Sigmoid Sinus Dural Arteriovenous Fistula by Direct Puncture of the Superior Sagittal Sinus.

Authors:  Simon Lammy; Joti Bhattacharya; James Dervin; Edward Jerome St George
Journal:  Asian J Neurosurg       Date:  2018 Jul-Sep
  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.